Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 DKK | +0.16% | -0.80% | -40.48% |
Sales 2024 * | 40M 5.75M | Sales 2025 * | - | Capitalization | 466M 67.02M |
---|---|---|---|---|---|
Net income 2024 * | -38M -5.46M | Net income 2025 * | - | EV / Sales 2024 * | 11.7 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-12.3
x | P/E ratio 2025 * |
-
| Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.17% |
Latest transcript on BioPorto A/S
1 day | +0.90% | ||
1 week | -2.07% | ||
Current month | -6.12% | ||
1 month | -6.97% | ||
3 months | -41.94% | ||
6 months | -18.35% | ||
Current year | -41.24% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 13-07-17 | |
Ursula Klause
CTO | Chief Tech/Sci/R&D Officer | - | 20-11-30 |
Prasad Devarajan
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John McDonough
CHM | Chairman | 65 | 21-04-28 |
Donnie Hardison
BRD | Director/Board Member | 74 | 21-04-28 |
Chief Executive Officer | 64 | 13-07-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.244 | +1.30% | 338 812 |
24-04-24 | 1.228 | -0.16% | 132,753 |
24-04-23 | 1.23 | +0.65% | 226,003 |
24-04-22 | 1.222 | -2.86% | 386,107 |
24-04-19 | 1.258 | +0.32% | 274,377 |
Delayed Quote Nasdaq Copenhagen, April 25, 2024 at 04:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.24% | 66.81M | |
-11.57% | 7.5B | |
+1.76% | 5.48B | |
+0.98% | 4.61B | |
+5.18% | 4.47B | |
-50.82% | 3.28B | |
+11.23% | 2.71B | |
-15.25% | 2.02B | |
-2.66% | 1.69B | |
-10.84% | 1.74B |
- Stock Market
- Equities
- BIOPOR Stock